DRIVIN G ROWTH - Dr. Reddy's
DRIVIN G ROWTH - Dr. Reddy's
DRIVIN G ROWTH - Dr. Reddy's
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
notes to the financial statements – DECEMBER 31, 2001<br />
These notes form an integral part of and should be read in conjunction with the accompanying financial statements.<br />
1. GENERAL<br />
The Company is incorporated in the Republic of Singapore with its principal place of business at:<br />
400 Orchard Road #11-11<br />
Orchard Towers<br />
Singapore 238875<br />
However, the registered office of the Company is at:<br />
17 Phillip Street #05-01<br />
Grand Building<br />
Singapore 048695<br />
The financial statements are expressed in Singapore dollars.<br />
The principal activities of the Company which is incorporated in Singapore are to act as importers, exporters, wholesalers, retailers,<br />
manufacturers, manufacturers’ agents and representatives, marketing agents, commission agents, distributors of medicinal and<br />
pharmaceutical products, health care, beauty care, toiletries and related items and provision of services to related corporations.<br />
The financial statements of the Company for the year ended December 31, 2001 were authorised for issue by Board of Directors<br />
at their meeting held on March 12, 2002.<br />
2. SIGNIFICANT ACCOUNTING POLICIES<br />
2.1 Basis of accounting<br />
The financial statements are prepared in accordance with the historical cost convention and the provisions of the Singapore<br />
Statements of Accounting Standard (“SAS”) and Singapore Companies Act.<br />
The immediate holding Company and related companies have provided financial support to the Company and the Directors<br />
are satisfied that they will continue to provide such support so as to enable the Company to meet its obligations as and when<br />
they fall due.<br />
The Company has adopted all the applicable new/revised SAS which becomes effective during the financial year. The adoption<br />
of the new/revised SAS does not affect the results of current financial year.<br />
2.2 Revenue recognition<br />
Revenue from sale of goods is recognised upon passage of title to the customer which coincides with their delivery and<br />
acceptance.<br />
Interest income is recognised on an accrual basis.<br />
Management fee income is based on service rendered.<br />
2.3 Fixed assets<br />
Fixed assets are stated at cost less accumulated depreciation. The cost of an asset comprises its purchase price and any directly<br />
attributable costs of bringing the asset to working condition for its intended use. Expenditure for additions, improvements and<br />
renewals are capitalised and expenditure for maintenance and repairs are charged to the Profit and Loss Statement. When<br />
assets are sold or retired, their cost and accumulated depreciation are removed from the accounts and any gain or loss resulting<br />
from their disposal is included in the Profit and Loss Statement.<br />
2.4 Depreciation<br />
Depreciation is calculated on a straight line method to write off the cost of the assets over their estimated useful lives. The<br />
estimated useful lives of fixed assets are as follows:<br />
Years<br />
Furniture & fixtures 5<br />
Office equipment 5<br />
Computers 3<br />
Fully depreciated assets are retained in the accounts until they are no longer in use and no further charge for depreciation is<br />
made in respect of these assets.<br />
REDDY PHARMACEUTICALS SINGAPORE PTE LTD. | FINANCIALS | ANNUAL REPORT 2001<br />
237